Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: A randomised trial

Thorax

Volumn 57, Issue 3, 2002, Pages 212-216

  Wolter, J ^a   Seeney, S ^a   Bell, S ^b   Bowler, S ^a   Masel, P ^b   McCormack, J ^a  

^a MATER ADULT HOSPITAL   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; C REACTIVE PROTEIN; IBUPROFEN; MACROLIDE; PLACEBO; PREDNISOLONE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL FLORA; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG CHOICE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; LUNG FUNCTION; LUNG WEIGHT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; SAMPLE SIZE; SIDE EFFECT; SPUTUM ANALYSIS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CYSTIC FIBROSIS; FEMALE; HUMANS; LONG-TERM CARE; MALE; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; QUALITY OF LIFE; SPUTUM; TREATMENT OUTCOME;

EID: 0036185807     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.3.212     Document Type: Article

References (24)

1. The use of anti-inflammatory medications in cystic fibrosis
2. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients
3. Study on azithromycin in treatment of diffuse panbronchiolitis
4. Elevated levels of soluble adhesion molecules in serum of patients with diffuse panbronchiolitis
5. Long-term azithromycin may improve lung function in children with cystic fibrosis
6. A measure of quality of life for clinical trials in chronic lung disease
7. Home intravenous therapy in cystic fibrosis: A prospective randomised trial examining clinical, quality of life and cost aspects
8. The adaptations of a quality of life questionnaire for routine use in clinical practice: The chronic respiratory disease questionnaire in cystic fibrosis
9. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
10. Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: A randomised, double-blind, placebo-controlled multicenter trial
11. Compliance with treatment in adult patients with cystic fibrosis
12. Treatment compliance in adults with cystic fibrosis
13. Clinical relevance of intracellular and extracellular concentrations of macrolides
14. Azithromycin reduces epithelial adherence of P aeruginosa in patients with cystic fibrosis
15. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells
16. Effect of clarithromycin and azithromycin on production of cytokines by human monocytes
17. Erythromycin suppresses nuclear factor-kappa B and activator protein-1 activation in human bronchial epithelial cells
18. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells
19. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro
20. Effect of macrolide antibiotics on neutrophil function in human peripheral blood
21. Effects of erythromycin on chemoattractant-activated human polymorphonuclear leukocytes
22. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics
23. Macrolides for the treatment of Pseudomonas aeruginosa infections?
24. Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis